Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium chloride + sodium lactate + sodium chloride + dextrose monohydrate + potassium chloride
- Development stage
- Approved
- Lead developer
- ICU Medical
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
calcium chloride + sodium lactate + sodium chloride + dextrose monohydrate + potassium chloride is a sterile intravenous crystalloid combination solution marketed as Lactated Ringer's and 5% Dextrose Injection. It combines electrolytes with dextrose to provide water, sodium, potassium, calcium, chloride, lactate, and carbohydrate calories for parenteral replacement of extracellular fluid and electrolyte losses, restoration of blood glucose, and alkalinization via hepatic metabolism of lactate to bicarbonate. The product is used in adults and pediatric patients as a source of water, electrolytes, and calories or as an alkalinizing agent, and has been manufactured/marketed by Hospira and ICU Medical.
- Brand names
- Lactated Ringer's and 5% Dextrose Injection
- Other names
- Lactated Ringer's and DextroseLactated Ringers and DextroseLactated Ringer's and Dextrose InjectionLactated Ringer's and Dextrose 5% InjectionPotassium chloride in Lactated Ringer's and Dextrose 5% Injection
Beyond the preview
Go deeper on calcium chloride + sodium lactate + sodium chloride + dextrose monohydrate + potassium chloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on calcium chloride + sodium lactate + sodium chloride + dextrose monohydrate + potassium chloride.